Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 4/20 | 0.61 |
| ▸ | CARM1 | Q86X55 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | DOT1L | Q8TEK3 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.50 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.50 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.50 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.50 |
| ▸ | GAPDH | P04406 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | STAT6 | P42226 | 1/20 | 0.50 |
| ▸ | PI4KA | P42356 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19927503 | 0.92 | AHCY (0.69) | AHCYCARM1ALDH1A1HIF1ADOT1L | |
| SCHEMBL19145745 | 0.86 | ADORA3 (0.66) | AHCYCARM1DOT1LADORA3SLC29A1 | |
| SCHEMBL19941881 | 0.85 | AHCY (0.61) | AHCYCARM1DOT1LADORA3SLC29A1 | |
| SCHEMBL8861594 | 0.82 | DNPH1 (0.70) | ALDH1A1ADORA1SMN1; SMN2 | |
| SCHEMBL8861547 | 0.79 | P2RX3 (0.69) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL21565155 | 0.77 | AHCY (0.53) | AHCYCARM1ALDH1A1HIF1ADOT1L | |
| SCHEMBL19927540 | 0.77 | AHCY (0.53) | AHCYCARM1ALDH1A1HIF1ADOT1L | |
| SCHEMBL19942001 | 0.77 | AHCY (0.63) | AHCYALDH1A1HIF1ADOT1LADORA3 | |
| SCHEMBL6900816 | 0.77 | ATM (0.76) | AHCYCARM1DOT1LADORA3SLC29A1 | |
| SCHEMBL15371600 | 0.76 | AHCY (1.00) | AHCYALDH1A1HIF1ADOT1LADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190345191-A1 | CYCLIC DINUCLEOTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH STING (STIMULATOR OF INTERFERON GENES) ACTIVITY | INNATE TUMOR IMMUNITY INC (US) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345191-A1 | CYCLIC DINUCLEOTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH STING (STIMULATOR OF INTERFERON GENES) ACTIVITY | STING1, CGAS, IRF3 | AHCY 1727/4885CARM1 3440/4885ALDH1A1 4646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.